The company is focused on robotic technology for spine surgical procedures. Here are five things to know about the company’s stock:
1. The one-year consensus price target is at $18.88.
2. The one-year high is $25.12 and the low is $9.63.
3. Mazor’s market cap is $246 million.
4. Zacks gave Mazor a 78 out of 265 industry rating based on competitors rating.
5. The 50-day moving average is $11; the 200-day moving average is $12.25.
More articles on orthopedic devices:
Spine device company stock report—5 key companies
Smith & Nephew revenue up 2% in 2014—10 things to know
27 spine devices receive FDA 510(k) in January
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
